COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,556 Articles (22,881 medRxiv, 8,675 bioRxiv)

Most recent first Previous |  Page 1816: Articles 18151-18160  | Next

Visuospatial processing impairment following mild COVID-19
DE PAULA, J. J., Paiva, R. E. R. P., Costa, D. d. S., Souza e Silva, N. G., Rosa, D. V., Januario, J. N., Silva, L. C., Miranda, D. M., Romano-Silva, M. A.
10.1101/2021.02.18.21251442 — Posted: 2021-02-20
Estimates of the COVID-19 pandemic dynamics in Ukraine based on two data sets
Nesteruk, I.
10.1101/2021.02.18.21252000 — Posted: 2021-02-20
Applicability of Neighborhood and Building Scale Wastewater-Based Genomic Epidemiology to Track the SARS-CoV-2 Pandemic and other Pathogens.
Spurbeck, R. R., Catlin, L. A., Minard-Smith, A. T.
10.1101/2021.02.18.21251939 — Posted: 2021-02-20
Profile of SARS-CoV-2-specific CD4 T cell response: Relationship with disease severity and impact of HIV-1 and active Mycobacterium tuberculosis co-infection
Riou, C., du Bruyn, E., Stek, C., Daroowala, R., Goliath, R. T., Abrahams, F., Said-Hartley, Q., Allowed, B. W., Hsiao, M., Wilkinson, K. A., Lindestam Arlehamn, C. S., Sette, A., Wasserman, S., Wilkinson, R. J., the HIATUS consortium
10.1101/2021.02.16.21251838 — Posted: 2021-02-20
Persisting adaptive immunity to SARS-CoV-2 in Lower Austria
Ladage, D., Harzer, O., Engel, P., Winkler, H., Braun, R.
10.1101/2021.02.18.21251551 — Posted: 2021-02-20
KLF2 is a therapeutic target for COVID-19 induced endothelial dysfunction
Xu, S., Luo, S., Zheng, X., Weng, J.
10.1101/2021.02.20.432085 — Posted: 2021-02-20
Statewide Impact of COVID-19 on Social Determinants of Health - A First Look: Findings from the Survey of the Health of Wisconsin
Malecki, K. M., Schultz, A. A., Nikodemova, M., Walsh, M. C., Bersch, A. J., Cronin, J., Cadmus-Bertram, L., Engelman, C., Lubsen, J. R., Peppard, P. E., Sethi, A. K.
10.1101/2021.02.18.21252017 — Posted: 2021-02-20
Association between Psychotropic Medications Functionally Inhibiting Acid Sphingomyelinase and reduced risk of Intubation or Death among Individuals with Mental Disorder and Severe COVID-19: an Observational Study
Hoertel, N., Sanchez-Rico, M., Gulbins, E., Kornhuber, J., Carpinteiro, A., Abellan, M., de la Muela, P., Vernet, R., Beeker, N., Neuraz, A., Delcuze, A., Alvarado, J. M., Meneton, P., Limosin, F.
10.1101/2021.02.18.21251997 — Posted: 2021-02-20
Impaired local intrinsic immunity to SARS-CoV-2 infection in severe COVID-19
Ziegler, C. G. K., Miao, V. N., Owings, A. H., Navia, A. W., Tang, Y., Bromley, J. D., Lotfy, P., Sloan, M., Laird, H., Williams, H. B., George, M., Drake, R. S., Christian, T., Parker, A., Sindel, C. B., Burger, M. W., Pride, Y., Hasan, M., Abraham, G. E., Senitko, M., Robinson, T. O., Shalek, A. K., Glover, S. C., Horwitz, B. H., Ordovas-Montanes, J.
10.1101/2021.02.20.431155 — Posted: 2021-02-20 Discussion: Offsite
Evaluation of rapid antibody test and chest computed tomography results of COVID-19 patients: A retrospective study
Ozturk, A., Bozok, T., Simsek Bozok, T.
10.1101/2021.02.15.21251772 — Posted: 2021-02-20

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).